Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection
To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consume...
Saved in:
| Published in | British journal of nutrition Vol. 111; no. 3; pp. 465 - 473 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cambridge, UK
Cambridge University Press
14.02.2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0007-1145 1475-2662 1475-2662 |
| DOI | 10.1017/S0007114513002547 |
Cover
| Abstract | To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 109 colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides–Prevotella, Bifidobacterium, Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. |
|---|---|
| AbstractList | To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomized into the L. acidophilus (dose 109 colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in fecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of fecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides-Prevotella, Bifidobacterium, Clostridium cluster XIVab and total fecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. [PUBLICATION ABSTRACT] To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 10⁹ colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides-Prevotella, Bifidobacterium, Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men.To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 10⁹ colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides-Prevotella, Bifidobacterium, Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 10⁹ colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides-Prevotella, Bifidobacterium, Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 10 super(9) colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides-Prevotella, Bifidobacterium, Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 10 9 colony-forming units twice daily; n 20) or the placebo ( n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides–Prevotella , Bifidobacterium , Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the present study, a parallel, double-blind, placebo-controlled 4-week intervention was performed in healthy males. The subjects largely consumed their habitual diet, but had to abstain from consuming dairy foods generally high in Ca. The subjects were randomised into the L. acidophilus (dose 109 colony-forming units twice daily; n 20) or the placebo (n 19) group. After an adaptation period of 2 weeks, the subjects were orally infected with a live, but attenuated, ETEC vaccine, able to induce mild, short-lived symptoms. Before and after the challenge, the subjects recorded stool consistency, bowel habits, and frequency and severity of gastrointestinal complaints. The ETEC challenge led to a significant increase in faecal output on the 2nd day and a concomitant increase in Bristol stool scale scores. Likewise, abdominal pain, bloating, flatulence, fever, headache and nausea peaked 1 d after the oral challenge. The concentrations of faecal calprotectin and IgA peaked 2 d after and that of serum IgM peaked 9 and 15 d after the oral challenge. The concentrations of serum IgA and IgG were unaffected. The ETEC challenge led to a reduction in the number of Bacteroides–Prevotella, Bifidobacterium, Clostridium cluster XIVab and total faecal bacteria. Probiotic treatment was associated with a larger increase in Bristol stool scale scores and more fever, headache and nausea after the ETEC challenge compared with the placebo treatment. These differences were, however, small and with substantial variation within the groups. Oral application of an attenuated live ETEC vaccine provides a useful model for food-borne infections. Supplementation with L. acidophilus ATCC 700396, however, was ineffective in reducing ETEC infection symptoms in healthy men. |
| Author | Alhoniemi, E. Bovee-Oudenhoven, I. M. J. ten Bruggencate, S. J. M. Ouwehand, A. C. Schonewille, A. J. Forssten, S. D. |
| Author_xml | – sequence: 1 givenname: A. C. surname: Ouwehand fullname: Ouwehand, A. C. organization: DuPont Nutrition and Health, Active Nutrition, Sokeritehtaantie 20, 02460 Kantvik, Finland – sequence: 2 givenname: S. J. M. surname: ten Bruggencate fullname: ten Bruggencate, S. J. M. email: sandra.tenbruggencate@nizo.com organization: Department of Health, NIZO Food Research, PO Box 20, 6710 BA Ede, The Netherlands – sequence: 3 givenname: A. J. surname: Schonewille fullname: Schonewille, A. J. organization: Department of Health, NIZO Food Research, PO Box 20, 6710 BA Ede, The Netherlands – sequence: 4 givenname: E. surname: Alhoniemi fullname: Alhoniemi, E. organization: Pharmatest Services Limited, Turku, Finland – sequence: 5 givenname: S. D. surname: Forssten fullname: Forssten, S. D. organization: DuPont Nutrition and Health, Active Nutrition, Sokeritehtaantie 20, 02460 Kantvik, Finland – sequence: 6 givenname: I. M. J. surname: Bovee-Oudenhoven fullname: Bovee-Oudenhoven, I. M. J. organization: Department of Health, NIZO Food Research, PO Box 20, 6710 BA Ede, The Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28216754$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23930950$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkkuL1TAYhoOMOGdGf4AbKYjgpppr0yxlGC9wwIW6LsnXdJpDm9QkhXHjbzflHC-M6Ky-hPd5X_guF-jMB28RekrwK4KJfP0JYywJ4YIwjKng8gHaES5FTZuGnqHdJtebfo4uUjqUb0uweoTOKVMMK4F36PteQw5Gg5umNVWl9mEZ3fZO67JMdrY-6-yCr5yvxnXWvgjmYCEX2vdVHq2LVbTJpaw92CqHqlhsDDncuhvrHVTXCUYbHYxOVxAmV6KGElBCH6OHg56SfXKql-jL2-vPV-_r_cd3H67e7Gvgjcq1NgaE0IpyQQegLRDKgAqjmDANEwBMUGbkYPQggQyKM94rBYoyzppW9OwSvTzmLjF8XW3K3ewS2GnS3oY1daQt46NStM39qKCYSSlwez_KlSKcUEoL-vwOeghr9KXnjRKKNxLzQj07UauZbd8t0c06fut-7qsAL06ATqCnIZaRu_SbaylppNiCyJGDGFKKdviFENxtt9P9dTvFI-94wB1Xn6N203-d7OTUs4muv7F_dPdP1w9eb9Xu |
| CODEN | BJNUAV |
| CitedBy_id | crossref_primary_10_1080_19490976_2021_1953246 crossref_primary_10_3390_biomedicines8040083 crossref_primary_10_1016_j_jpba_2018_03_009 crossref_primary_10_1038_s41598_021_85161_1 crossref_primary_10_2217_fmb_2016_0101 crossref_primary_10_1371_journal_pone_0279626 crossref_primary_10_1017_S0029665122002853 crossref_primary_10_1111_apt_14539 crossref_primary_10_1016_j_clnu_2023_01_001 crossref_primary_10_3390_nu14061204 crossref_primary_10_1017_S0007114516004037 crossref_primary_10_1519_JSC_0000000000001456 crossref_primary_10_3945_jn_115_214098 crossref_primary_10_2903_sp_efsa_2015_EN_758 crossref_primary_10_1016_j_advnut_2023_02_002 crossref_primary_10_1016_j_foodhyd_2017_07_009 crossref_primary_10_3748_wjg_v20_i33_11878 crossref_primary_10_1371_journal_pone_0281817 crossref_primary_10_4081_cp_2017_987 crossref_primary_10_1038_ejcn_2014_238 crossref_primary_10_3390_nu13072155 |
| Cites_doi | 10.1016/j.tmaid.2005.10.003 10.1111/j.1574-695X.2008.00413.x 10.1371/journal.pone.0034938 10.1017/S0007114508003097 10.1146/annurev.immunol.021908.132657 10.3748/wjg.14.53 10.1186/1471-2334-10-330 10.1016/S0016-5085(03)00884-9 10.1093/ajcn/39.5.756 10.1177/154510970400300403 10.1128/AEM.70.11.6459-6465.2004 10.1097/MCG.0b013e31820ca4d6 10.1016/S1043-4526(08)00601-3 10.1136/gut.32.1.73 10.1002/ibd.20920 10.1046/j.1365-2672.2002.01767.x 10.1207/s15327914nc5201_12 10.1128/AEM.68.10.4986-4995.2002 10.1099/jmm.0.47615-0 10.1111/j.1365-2672.2004.02409.x 10.1093/jn/136.1.70 |
| ContentType | Journal Article |
| Copyright | Copyright © The Authors 2013 2015 INIST-CNRS |
| Copyright_xml | – notice: Copyright © The Authors 2013 – notice: 2015 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7T5 7X2 7X7 7XB 88E 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB0 M0K M0S M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 7QL C1K 7S9 L.6 |
| DOI | 10.1017/S0007114513002547 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Immunology Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agriculture Science Database Health & Medical Collection (Alumni) Medical Database Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE - Academic MEDLINE Bacteriology Abstracts (Microbiology B) CrossRef AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Diet & Clinical Nutrition |
| DocumentTitleAlternate | A. C. Ouwehand et al. Effects of dietary Lactobacillus acidophilus |
| EISSN | 1475-2662 |
| EndPage | 473 |
| ExternalDocumentID | 3209590371 23930950 28216754 10_1017_S0007114513002547 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -1D -2P -E. -~6 -~X .FH 09C 09E 0E1 0R~ 23N 2WC 4.4 5GY 5RE 5VS 6J9 6PF 74X 74Y 7RV 7X2 7X7 7~V 88E 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 9M5 AAAZR AABES AABWE AACJH AAFWJ AAGFV AAHBH AAIKC AAKTX AAMNQ AAMNW AANRG AARAB AASVR AATID AATMM AAUIS AAUKB AAWTL AAZAQ ABBXD ABFBI ABGDZ ABJNI ABKKG ABKMT ABMWE ABQTM ABROB ABUWG ABVKB ABVZP ABWCF ABXAU ABXHF ABZCX ACBEK ACBMC ACDLN ACGFS ACIMK ACPRK ACUIJ ACYZP ACZBM ACZUX ACZWT ADAZD ADBBV ADDNB ADFEC ADFRT ADKIL ADVJH AEBAK AEHGV AEMTW AENEX AENGE AEPLO AEUYN AEYHU AFFUJ AFKQG AFKRA AFLOS AFLVW AFOSN AFRAH AFRIC AFUTZ AFZFC AGABE AGJUD AGLWM AHIPN AHLTW AHMBA AHQXX AHRGI AIGNW AIHIV AIOIP AISIE AJ7 AJCYY AJPFC AJQAS ALMA_UNASSIGNED_HOLDINGS ALWZO AN0 ANPSP AQJOH ARABE ATCPS ATUCA AUXHV AYIQA AZGZS AZQEC BAWUL BBLKV BENPR BHPHI BKEYQ BLZWO BMAJL BNQBC BPHCQ BQFHP BRIRG BVXVI C0O CBIIA CCPQU CCQAD CFAFE CHEAL CJCSC CS3 DIK DOHLZ DU5 DWQXO E3Z EBS EJD EX3 F5P FYUFA GNUQQ GUQSH HCIFZ HG- HH5 HMCUK HST HZ~ I.6 I.7 IH6 IOEEP IOO IS6 I~P J36 J38 J3A JHPGK JKPOH JQKCU JVRFK KCGVB KFECR L7B L98 LHUNA LW7 M-V M0K M1P M2O M7~ NAPCQ NIKVX O9- OK1 OVD P6G PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RAMDC RCA RIG ROL RR0 S6- S6U SAAAG SJN SY4 T9M TEORI TR2 UKHRP UT1 UU6 WFFJZ WH7 WOW WQ3 WXU WYP Y6R ZMEZD ZYDXJ ~KM AAYXX AKMAY CITATION -1F -2V -~N .55 .GJ 354 3EH 3O- 53G 6~7 AAYJJ ABBZL ABHFL ABVFV ABZUI ACEJA ACETC ACOZI ACRPL ADNMO ADOVH ADOVT AEBPU AEMFK AENCP AFFNX AGKLZ AI. AKZCZ ALEEW ANOYL ARZZG BCGOX BESQT BGHMG BJBOZ C1A CAG CCUQV CDIZJ CFBFF CGQII COF EGQIC I.9 IQODW KAFGG M8. NMFBF NZEOI OHT UAP VH1 X7M ZCG ZDLDU ZGI ZJOSE ZXP ~V1 AAKNA AGQPQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7QP 7T5 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 PUEGO 7QL C1K 7S9 L.6 |
| ID | FETCH-LOGICAL-c469t-abbc55a92452fc28c123c25b935b635cc3523b7fbaf7c1f9434d99c92343685d3 |
| IEDL.DBID | 8C1 |
| ISSN | 0007-1145 1475-2662 |
| IngestDate | Fri Sep 05 05:41:47 EDT 2025 Thu Sep 04 22:53:51 EDT 2025 Fri Sep 05 09:02:54 EDT 2025 Sat Aug 23 12:53:30 EDT 2025 Mon Jul 21 05:50:07 EDT 2025 Wed Apr 02 07:35:46 EDT 2025 Tue Jul 01 03:50:17 EDT 2025 Thu Apr 24 23:03:15 EDT 2025 Sun Jun 15 04:39:38 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Probiotics Microbiota Lactobacillus acidophilus Intestinal infection Enterotoxigenic Escherichia coli Endocrinopathy Human Probiotic Nutrition Digestive system Escherichia coli Gut Microflora Feeding Infection Target tissue resistance Bacteria Lactobacillaceae Supplementation Enterobacteriaceae |
| Language | English |
| License | https://www.cambridge.org/core/terms CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c469t-abbc55a92452fc28c123c25b935b635cc3523b7fbaf7c1f9434d99c92343685d3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 23930950 |
| PQID | 1495946704 |
| PQPubID | 5629 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_1825427586 proquest_miscellaneous_1520377508 proquest_miscellaneous_1499141222 proquest_journals_1495946704 pubmed_primary_23930950 pascalfrancis_primary_28216754 crossref_primary_10_1017_S0007114513002547 crossref_citationtrail_10_1017_S0007114513002547 cambridge_journals_10_1017_S0007114513002547 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-02-14 |
| PublicationDateYYYYMMDD | 2014-02-14 |
| PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-14 day: 14 |
| PublicationDecade | 2010 |
| PublicationPlace | Cambridge, UK |
| PublicationPlace_xml | – name: Cambridge, UK – name: Cambridge – name: England |
| PublicationTitle | British journal of nutrition |
| PublicationTitleAlternate | Br J Nutr |
| PublicationYear | 2014 |
| Publisher | Cambridge University Press |
| Publisher_xml | – name: Cambridge University Press |
| References | Lahtinen, Forssten, Aakko (23) 2011; 34 Ouwehand, Tiihonen, Saarinen (2) 2009; 101 Lahtinen, Forssten, Aakko (12) 2012; 12 Corr, Hill, Gahan (19) 2009; 56 Apajalahti, Kettunen, Kettunen (11) 2002; 68 Engelbrektson, Korzenik, Pittler (4) 2009; 58 Ritchie, Romanuk (20) 2012; 7 Ringel-Kulka, Palsson, Maier (18) 2011; 45 Song, Liu, Finegold (24) 2004; 70 Sui, Leighton, Busta (3) 2002; 93 McFarland (14) 2007; 5 Rinttilä, Kassinen, Malinen (21) 2004; 97 Bovee-Oudenhoven, Lettink-Wissink, Van Doesburg (9) 2003; 125 Ten Bruggencate, Bovee-Oudenhoven, Lettink-Wissink (10) 2006; 136 Xiang, Ouyang, Li (16) 2008; 14 Simenhoff, Dunn, Zollner (6) 1996; 22 Heiser, Ernst, Barrett (8) 2004; 3 Heaton, Ghosh, Braddon (13) 1991; 32 Gisbert, McNicholl, Gomollon (15) 2009; 15 Goldin, Gorbach (5) 1984; 39 Mäkivuokko, Nurmi, Nurminen (22) 2005; 52 Izcue, Coombes, Powrie (17) 2009; 27 Field, Gautret, Schlagenhauf (1) 2010; 10 Paineau, Carcano, Leyer (7) 2008; 53 S0007114513002547_ref7 S0007114513002547_ref8 S0007114513002547_ref9 (S0007114513002547_ref6) 1996; 22 (S0007114513002547_ref10) 2006; 136 (S0007114513002547_ref12) 2012; 12 S0007114513002547_ref18 S0007114513002547_ref19 S0007114513002547_ref16 S0007114513002547_ref17 S0007114513002547_ref14 S0007114513002547_ref15 S0007114513002547_ref13 S0007114513002547_ref24 S0007114513002547_ref21 S0007114513002547_ref11 (S0007114513002547_ref5) 1984; 39 S0007114513002547_ref22 S0007114513002547_ref1 (S0007114513002547_ref23) 2011; 34 S0007114513002547_ref20 S0007114513002547_ref2 S0007114513002547_ref3 S0007114513002547_ref4 |
| References_xml | – volume: 34 start-page: 133 year: 2011 end-page: 143 ident: 23 article-title: Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly publication-title: Age – volume: 70 start-page: 6459 year: 2004 end-page: 6465 ident: 24 article-title: Real-time PCR quantitation of clostridia in feces of autistic children publication-title: Appl Environ Microbiol – volume: 12 start-page: 133 year: 2012 end-page: 143 ident: 12 article-title: Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly publication-title: Age (Dordr) – volume: 45 start-page: 518 year: 2011 end-page: 525 ident: 18 article-title: Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study publication-title: J Clin Gastroenterol – volume: 101 start-page: 367 year: 2009 end-page: 375 ident: 2 article-title: Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters publication-title: Br J Nutr – volume: 5 start-page: 97 year: 2007 end-page: 105 ident: 14 article-title: Meta-analysis of probiotics for the prevention of traveler's diarrhea publication-title: Travel Med Infect Dis – volume: 27 start-page: 313 year: 2009 end-page: 338 ident: 17 article-title: Regulatory lymphocytes and intestinal inflammation publication-title: Annu Rev Immunol – volume: 15 start-page: 1746 year: 2009 end-page: 1754 ident: 15 article-title: Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease publication-title: Inflamm Bowel Dis – volume: 14 start-page: 53 year: 2008 end-page: 57 ident: 16 article-title: Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis publication-title: World J Gastroenterol – volume: 97 start-page: 1166 year: 2004 end-page: 1177 ident: 21 article-title: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR publication-title: J Appl Microbiol – volume: 22 start-page: 92 year: 1996 end-page: 96 ident: 6 article-title: Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus publication-title: Miner Electrolyte Metab – volume: 56 start-page: 1 year: 2009 end-page: 15 ident: 19 article-title: Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens publication-title: Adv Food Nutr Res – volume: 53 start-page: 107 year: 2008 end-page: 113 ident: 7 article-title: Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial publication-title: FEMS Immunol Med Microbiol – volume: 10 start-page: 330 year: 2010 ident: 1 article-title: Travel and migration associated infectious diseases morbidity in Europe, 2008 publication-title: BMC Infect Dis – volume: 136 start-page: 70 year: 2006 end-page: 74 ident: 10 article-title: Dietary fructooligosaccharides affect intestinal barrier function in healthy men publication-title: J Nutr – volume: 39 start-page: 756 year: 1984 end-page: 761 ident: 5 article-title: The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity publication-title: Am J Clin Nutr – volume: 58 start-page: 663 year: 2009 end-page: 670 ident: 4 article-title: Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy publication-title: J Med Microbiol – volume: 125 start-page: 469 year: 2003 end-page: 476 ident: 9 article-title: Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium publication-title: Gastroenterology – volume: 93 start-page: 907 year: 2002 end-page: 912 ident: 3 article-title: 16S Ribosomal DNA analysis of the faecal lactobacilli composition of human subjects consuming a probiotic strain Lactobacillus acidophilus NCFM publication-title: J Appl Microbiol – volume: 32 start-page: 73 year: 1991 end-page: 79 ident: 13 article-title: How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form publication-title: Gut – volume: 3 start-page: 121 year: 2004 end-page: 129 ident: 8 article-title: Probiotics, soluble fiber, and l-glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea publication-title: J Int Assoc Physicians AIDS Care (Chic) – volume: 68 start-page: 4986 year: 2002 end-page: 4995 ident: 11 article-title: Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum publication-title: Appl Environ Microbiol – volume: 7 start-page: e34938 year: 2012 ident: 20 article-title: A meta-analysis of probiotic efficacy for gastrointestinal diseases publication-title: PLOS ONE – volume: 52 start-page: 94 year: 2005 end-page: 104 ident: 22 article-title: In vitro effects on polydextrose by colonic bacteria and caco-2 cell cyclooxygenase gene expression publication-title: Nutr Cancer – ident: S0007114513002547_ref14 doi: 10.1016/j.tmaid.2005.10.003 – ident: S0007114513002547_ref7 doi: 10.1111/j.1574-695X.2008.00413.x – ident: S0007114513002547_ref20 doi: 10.1371/journal.pone.0034938 – volume: 22 start-page: 92 year: 1996 ident: S0007114513002547_ref6 publication-title: Miner Electrolyte Metab – ident: S0007114513002547_ref2 doi: 10.1017/S0007114508003097 – ident: S0007114513002547_ref17 doi: 10.1146/annurev.immunol.021908.132657 – ident: S0007114513002547_ref16 doi: 10.3748/wjg.14.53 – ident: S0007114513002547_ref1 doi: 10.1186/1471-2334-10-330 – ident: S0007114513002547_ref9 doi: 10.1016/S0016-5085(03)00884-9 – volume: 39 start-page: 756 year: 1984 ident: S0007114513002547_ref5 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/39.5.756 – ident: S0007114513002547_ref8 doi: 10.1177/154510970400300403 – volume: 12 start-page: 133 year: 2012 ident: S0007114513002547_ref12 publication-title: Age (Dordr) – ident: S0007114513002547_ref24 doi: 10.1128/AEM.70.11.6459-6465.2004 – ident: S0007114513002547_ref18 doi: 10.1097/MCG.0b013e31820ca4d6 – ident: S0007114513002547_ref19 doi: 10.1016/S1043-4526(08)00601-3 – ident: S0007114513002547_ref13 doi: 10.1136/gut.32.1.73 – volume: 34 start-page: 133 year: 2011 ident: S0007114513002547_ref23 publication-title: Age – ident: S0007114513002547_ref15 doi: 10.1002/ibd.20920 – ident: S0007114513002547_ref3 doi: 10.1046/j.1365-2672.2002.01767.x – ident: S0007114513002547_ref22 doi: 10.1207/s15327914nc5201_12 – ident: S0007114513002547_ref11 doi: 10.1128/AEM.68.10.4986-4995.2002 – ident: S0007114513002547_ref4 doi: 10.1099/jmm.0.47615-0 – ident: S0007114513002547_ref21 doi: 10.1111/j.1365-2672.2004.02409.x – volume: 136 start-page: 70 year: 2006 ident: S0007114513002547_ref10 publication-title: J Nutr doi: 10.1093/jn/136.1.70 |
| SSID | ssj0008109 |
| Score | 2.2129216 |
| Snippet | To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the... To assess the effect of Lactobacillus acidophilus (American Type Culture Collection (ATCC) 700396) on enterotoxigenic Escherichia coli (ETEC) infection, in the... |
| SourceID | proquest pubmed pascalfrancis crossref cambridge |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 465 |
| SubjectTerms | Abdominal Pain - etiology Abdominal Pain - prevention & control Adult bacteria Bifidobacterium Biological and medical sciences blood serum Clostridium dairy products Diarrhea - etiology Diarrhea - prevention & control diet Disease Resistance Double-Blind Method E coli enterotoxigenic Escherichia coli Enterotoxigenic Escherichia coli - immunology Escherichia coli Escherichia coli Infections - immunology Escherichia coli Infections - microbiology Escherichia coli Infections - physiopathology Escherichia coli Infections - prevention & control Escherichia coli Vaccines - adverse effects Escherichia coli Vaccines - immunology feces Feces - chemistry Feces - microbiology Feeding. Feeding behavior fever flatulence Foodborne diseases Foodborne Diseases - immunology Foodborne Diseases - microbiology Foodborne Diseases - physiopathology Foodborne Diseases - prevention & control foodborne illness Fundamental and applied biological sciences. Psychology Gastroenteritis - immunology Gastroenteritis - microbiology Gastroenteritis - physiopathology Gastroenteritis - prevention & control Gastrointestinal diseases gastrointestinal system headache Humans immunoglobulin A Immunoglobulin A - analysis immunoglobulin G immunoglobulin M Immunoglobulin M - analysis Infections Lactobacillus acidophilus Lactobacillus acidophilus - immunology Leukocyte L1 Antigen Complex - analysis Male males men Microbiology nausea placebos Probiotics Probiotics - adverse effects Probiotics - therapeutic use Severity of Illness Index Vaccines Vaccines, Attenuated - adverse effects Vaccines, Attenuated - immunology Vertebrates: anatomy and physiology, studies on body, several organs or systems Young Adult |
| Title | Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection |
| URI | https://www.cambridge.org/core/product/identifier/S0007114513002547/type/journal_article https://www.ncbi.nlm.nih.gov/pubmed/23930950 https://www.proquest.com/docview/1495946704 https://www.proquest.com/docview/1499141222 https://www.proquest.com/docview/1520377508 https://www.proquest.com/docview/1825427586 |
| Volume | 111 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZNcimU0HedpkaF0kOpqa2HbZ1Cmm4IpV1KaWBviyVL1LDYm9gLOfW3d0Z-JKHUp13wCIQ08nyjGX8fIe-sNC6FSBzx2EGCoksWaevyKHYiZZaLXDq8Gvi-TC8uxdeVXA0Xbu3QVjm-E_2LumwM3pF_QiSPcvCxONleRagahdXVQUJjjxzgN6CYfOVnty0eeTK0eCARYiLkWNX0lNEYXFGmlvsPwrO73Ar3YtSjbdHCcrle5-L_QNQHpPPH5HBAkvS03_on5IGtn5LgS2U7-p4OdJ8buhzZ9p-RP99QW0cXptpsdi2F37LZ_q7wf4vann0fOdrSqqZevA8eaLyoAeu6pL6oQCE_R8wJzkK7hiKl53XTNTfI6lkZumjRCyrsoKbgYxUdu73q5-TyfPHr7CIa5BciAzlzFxVaGykLhbVZZ1huIMgZJrXiUgNMMQawG9eZ04XLTOKQaK5UygBi9Kz2JX9B9uumtq8IzSWTTjmBdViRIMGM0oArrE2Vi8skDcjHafHXwyFq130DWrb-Z68CEo_7szYDlTkqamzmhnyYhmx7Ho854_Depk8jID9NIMMSATkeveDOdCcPDcjb6TGcVizBFLVtdt5GJbACjM3YSBbzDJBcPmODiT2DXA-W7mXvhbeT5IoDcI6P5if5mjwE8CewAz0Rx2S_u97ZNwCwOh2SvWyVhf4sheTg82L542eIIU_-BX6mIlA |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEkhHizUIqRgAMiInHsPA4VArrVlm5XCLVSb9vYsUWkVbJssgIu_DR-GzN50QqRW08bKeNV5Bl7Zjzj7wN4YaS2AXpix3ctJigq5Y4yNnJcKwJufBFJS0cDx_Ngeio-ncmzLfjd3YWhtspuT6w36rTQdEb-liJ5ooN3xbvVN4dYo6i62lFoJC21QrpXQ4y1FzuOzM_vmMKVe4f7qO-XnB9MTj5OnZZlwNGYGlZOopSWMompBGk1jzTu5ZpLFftSoTfWGkMUX4VWJTbUniU8tTSONQZGNXh76uP_XoNtQQcoI9j-MJl__tL7gshrm0wIitETsqur1qDV5N6JKNevr6SHF9EdLnnJm6ukRIXZhmnj_6Fw7RIPbsOtNpZl7xvjuwNbJr8L4_3MVOwVawFHl2ze4f3fg18zYvdRic6Wy03J8DctVl8zei6JXbTpZCdZluWspg_EF4qOilA6T1ld1mBrU1LUi-bKqoIRqOi6qIofhCuaaTYpyQ4z6uFmaOUZ6_rN8vtweiWqeQCjvMjNI2CR5NLGVlAlWHgEcRMrjGyMCWLrpl4whjf95C_aZVwumha4cPGPrsbgdvpZ6BZMnTg9lkNDXvdDVg2SyJDw7iWl9yMwQ_YwxxNj2Oms4MLn9mtkDM_717hfUBEoyU2xqWViD2eA8wEZyV0_xFgyGpChowWO2SZO3cPGCv9-pB_7GLq7j4c_8hlcn54czxazw_nRE7iBoaigfnhP7MCoWm_MUwz3KrXbrikG51e9jP8AuSxiDA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Li9RAEG7WFUQQ8W10XVtQD2LYpB9J-iAizg677jp4cGFuMd3pxsCQjJMM6sUf5q-zKi93EXPb0wRSPTRd1V1fdVW-IuS5lcZF4Il9HjgIUHTOfG1d4gdORMxykUiHVwMfF9HRmfiwlMsd8nv4FgbLKoczsT2o88rgHfkBInlsBx-IA9eXRXyazd-uv_nYQQozrUM7jc5ETuzP7xC-1W-OZ6DrF4zNDz-_P_L7DgO-gbCw8TOtjZSZwvSjMywxcI4bJrXiUoMnNgbgCdex05mLTeiQSy1XygAoaonbcw7_e4VcjbkQ2DYiXo7BHnjavrwESRhDIYeMaktXjY4dW-Ty9mP0-DyvwwX_eGOd1aAq1_XY-D8Ibp3h_Ba52aNY-q4zu9tkx5Z3iDcrbENf0p5qdEUXA9P_XfLrFPv66MwUq9W2pvCbV-uvBT7X2Fe0q2FHWVqUtG0cCC80XhKBdJnTNqFBN7ZGvAuGSpuKIp3opmqqH8goWhh6WKMFFli9TcG-CzpUmpX3yNmlKOY-2S2r0j4kNJFMOuUE5oBFiOQ2SgOmsTZSLsjDyCOvx8VP-w1cp13xW5z-oyuPBIN-UtPTqGM3j9XUkFfjkHXHITIlvH9B6eMIiI1DiO6ER_YGKzg33XF3eOTZ-BpOCkz_ZKWttq2MCmEFGJuQkSzgMaDIZEIGLxUYxJmwdA86K_w7Sa44gPbg0fQkn5JrsHnT0-PFyWNyHTCowEL4UOyR3WaztU8A5zV6v91QlHy57B38B_gNX6g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lactobacillus+acidophilus+supplementation+in+human+subjects+and+their+resistance+to+enterotoxigenic+Escherichia+coli+infection&rft.jtitle=British+journal+of+nutrition&rft.au=Ouwehand%2C+A+C&rft.au=ten+Bruggencate%2C+S+J+M&rft.au=Schonewille%2C+A+J&rft.au=Alhoniemi%2C+E&rft.date=2014-02-14&rft.pub=Cambridge+University+Press&rft.issn=0007-1145&rft.eissn=1475-2662&rft.volume=111&rft.issue=3&rft.spage=465&rft_id=info:doi/10.1017%2FS0007114513002547&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3209590371 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1145&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1145&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1145&client=summon |